0001593968-22-001741.txt : 20221219
0001593968-22-001741.hdr.sgml : 20221219
20221219162416
ACCESSION NUMBER: 0001593968-22-001741
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221216
FILED AS OF DATE: 20221219
DATE AS OF CHANGE: 20221219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ignelzi Troy A.
CENTRAL INDEX KEY: 0001579829
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38958
FILM NUMBER: 221471398
MAIL ADDRESS:
STREET 1: C/O ESPERION THERAPEUTICS, INC.
STREET 2: 46701 COMMERCE CENTER DRIVE
CITY: PLYMOUTH
STATE: MI
ZIP: 48170
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karuna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771917
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270605902
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-449-2244
MAIL ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2022-12-16
0001771917
Karuna Therapeutics, Inc.
KRTX
0001579829
Ignelzi Troy A.
C/O KARUNA THERAPEUTICS, INC.
99 HIGH STREET, 26TH FLOOR
BOSTON
MA
02110
false
true
false
false
Chief Financial Officer
Common Stock
2022-12-16
4
M
false
10869
9.2
A
20839
D
Common Stock
2022-12-16
4
M
false
371
9.2
A
21210
D
Common Stock
2022-12-16
4
M
false
627
9.2
A
21837
D
Option (right to buy)
9.20
2022-12-16
4
M
false
10869
0
D
2029-03-21
Common Stock
10869
110743
D
Option (right to buy)
9.20
2022-12-16
4
M
false
371
0
D
2029-03-28
Common Stock
371
8559
D
Option (right to buy)
9.20
2022-12-16
4
M
false
627
0
D
2029-04-07
Common Stock
627
626
D
This option vested and became exercisable as to 1/4th of the shares underlying the option award on March 1, 2020, and continues to vest as to an additional 1/8th of the shares on each six month anniversary thereafter.
This option vested as to 1/36th of the shares underlying the option award on each one month anniversary of the vesting commencement date of March 1, 2019.
/s/ Troy Ignelzi
2022-12-19